Liver cancer is one of the most common causes of cancer mortality worldwide.
Chemotherapy and radiotherapy are the conventional therapies generally employed in …

Enhanced cancer treatment remains as one of the focused areas for researchers around the
world. Hence, the progress in this direction will be a challenge and an opportunity in, inter …

To overcome drug resistance and improve precision theranostics for hepatocellular
carcinoma (HCC), a nanoplatform with an “off/on” function for multimodality imaging (near …

The lack of cancer cell specificity and the occurrence of multidrug resistance (MDR) are two
major obstacles in the treatment of hepatocellular carcinoma (HCC). To tackle these …

Nucleic acid (NA) therapeutics are a rapidly growing class of biomedicines with the ability to
manipulate gene expression in potent and specific manner, and with the enormous potential …

Inorganic materials, in particular nanoclays and silica nanoparticles, have attracted
enormous attention due to their versatile and tuneable properties, making them ideal …

Hepatoma is one of the most severe malignancies usually with poor prognosis, and many
patients are insensitive to the existing therapeutic agents, including the drugs for …

Evoking ferroptosis of cancer cells is a useful strategy to prevent tumor growth and
metastasis. However, intrinsic ferroptosis suppressors glutathione peroxidase 4 (GPX4) and …

A bifunctional hepatocyte-mitochondrion targeting nanosystem was prepared for astaxanthin
by conjugating lactobionic acid (LA) and triphenylphosphonium-modified 2-hydroxypropyl-β …

Two synthetic supramolecular hydrogels, formed from bis-urea amphiphiles containing
lactobionic acid (LBA) and maltobionic acid (MBA) bioactive ligands, are applied as cell …